Medical Health & Life Science Research News

Active pharmaceutical ingredients (api) market to reach USD 224.63 billion by 2022 according to new research report

The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

- Agency -.

According to the new market research report, “Active Pharmaceutical Ingredients (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022”, published by Scalar Market Research, the global active pharmaceutical ingredient (API) market is expected to grow at a steady CAGR of 6.4% and reach USD 224.63 billion by the year 2022.

Report: www.scalarmarketresearch.com/request-sample.php?id=30

Key findings of the report:

  • According to the report, the rapid advancements in biologics are one of the major driving factors for the global active pharmaceutical ingredients (API) market.
     
  • Apart from that, the rising local manufacturing and the growth in the number of aging population are also expected to drive the global active pharmaceutical ingredient (API) market during the forecast period.
     
  • The increasing awareness towards generic drugs and the growing government initiatives are also expected to boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.

Detailed segmentation analysis of the active pharmaceutical ingredients (API) market

The report segments the global active pharmaceutical ingredient (API) market by manufacturers, synthesis, drug types, classifications, therapeutic areas, and geographic regions. The manufacturer segments are further divided into merchant and captive.

The synthesis segment includes biological and synthetic.

- Agency -.

The drug types include generic and branded.

The classifications include HPAPI and others. The therapeutic areas include metabolic disorders, cardiovascular diseases, NSAIDs, CNS, musculoskeletal diseases, oncology, and others.

Based on the geographic regions, the global active pharmaceutical ingredient (API) market is further divided into North America, Asia-Pacific, Europe, and Rest of the World.

Browse Report: www.scalarmarketresearch.com/marke…dients-api-market

The active pharmaceutical ingredients (API) market report provides analysis of the key players, including:

  • Teva Pharmaceutical Industries, Ltd
  • Sun Pharmaceutical Industries Ltd
  • Dr.Reddy’s Laboratories
  • Aurobindo Pharma Ltd
  • Mylan N.V
  • Novartis AG
  • Cambrex Corporation
  • Boehringer Ingelheim GmbH
  • Pfizer, Inc
  • Lonza Group

 

News From

Scalar Market Research - Market ReportsScalar Market Research
Category: Market Research Publishers and RetailersCompany profile: Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers acrystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast. Find out more about ...